Effect of intranasal administration of semliki forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis

Author： Jerusalmi A.   Morris-Downes M.M.   Sheahan B.J.   Atkins G.J.  

Publisher： Elsevier

ISSN： 1525-0016

Source： Molecular Therapy, Vol.8, Iss.6, 2003-12, pp. : 886-894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Blocking GluR2–GAPDH ameliorates experimental autoimmune encephalomyelitis

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 4, 2015-04 ,pp. : 388-400

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel semliki forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression

By Lundstrom K.   Abenavoli A.   Malgaroli A.   Ehrengruber M.U.  

Molecular Therapy, Vol. 7, Iss. 2, 2003-02 ,pp. : 202-209

Elsevier

Access to resources Recommend Favorite

Intranasal Administration of Influenza Vaccines: Current Status

By Eyles J.E.  

BioDrugs, Vol. 13, Iss. 1, 2000-01 ,pp. : 35-59

Adis International

Access to resources Recommend Favorite

The primate autoimmune encephalomyelitis model; a bridge between mouse and man

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 5, 2015-05 ,pp. : 581-593

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intramuscular Administration of Recombinant Adeno-Associated Virus 2 -1 Antitrypsin (rAAV-SERPINA1) Vectors in a Nonhuman Primate Model: Safety and Immunologic Aspects

By Song S.   Scott-Jorgensen M.   Wang J.   Poirier A.   Crawford J.   Campbell-Thompson M.   Flotte T.R.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 329-335

Elsevier

Access to resources Recommend Favorite